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KEY POINTS 
  
1) Hypertension is common, particularly in older cats and those with co-morbidities such as chronic kidney 
disease, acute kidney injury and hyperthyroidism 
2) Blood pressure measurement should be considered in at risk cats; those with co-morbidities, cats exposed 
to pharmacological agents or toxins associated with hypertension and those over nine years of age 
3) Target organ damage (TOD) affecting the eyes, brain, heart/vasculature and kidneys have all been 
documented in cats and the rationale for treatment is to prevent TOD occurring 
4) Treatment should always be administered even if TOD has already been documented, as there is evidence 





Hypertension is a common problem, particularly in older cats. Hypertension secondary to a concurrent disease 
is the most common form of hypertension in this species, particularly in association with chronic kidney 
disease or hyperthyroidism. However, idiopathic hypertension may account for up to 24% of cases. Any form 
of persistent hypertension risks target organ damage (TOD) to the eyes, brain, kidney and 
myocardium/vasculature, therefore measurement of blood pressure is vital in at risk cats to try and identify 
occult hypertension before TOD occurs. This article addresses when and how to perform blood pressure 







It is vital to think about the possibility of hypertension in cats that may be at risk of this condition, 
because patients rarely have overt warning clinical signs. It is devastating for your patient (and their 
owner) if they lose their sight due to a condition that wasn’t checked for, but so easily could have been 
(see Figure 1). Untreated hypertension also puts the other target organs at risk of damage, resulting 
in increased morbidity and mortality. This condition is common; a recent epidemiological study of cats 
in the UK found an incidence risk of 19.5%.1 This article will discuss how we define hypertension, which 
cats are at risk, when to monitor blood pressure (BP), and how we can apply evidence-based medicine 




Although it is possible to measure systolic arterial blood pressure, diastolic arterial blood pressure and 
to calculate mean arterial blood pressure, measurements of systolic arterial blood pressure (SBP) are 
considered to be the most reliable in cats and are therefore used for recommendations of when to 
treat and how to monitor for treatment response. Studies that have tried to establish what a “normal” 
SBP is in healthy cats have had varied results, but one study that measured blood pressure in almost 
780 healthy cats in a rehoming center found the median SBP was 120mmHg (interquartile range 110-
132mmHg).2 This study also found that median SBP increased with age in healthy cats, with cats  9 
years of age having significantly higher SBP than cats aged 3-9 years, although the difference between 
the median measurements was only approximately 10mmHg. The proportion of cats that developed 
hypertension also increased with advancing age in a study of healthy cats and cats with CKD.3 
However, not all studies have found consistent results regarding age and increasing blood pressure.4,5  
 
The latest ACVIM guidelines4 on hypertension define the following categories for SBP: 
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 Normotensive < 140mmHg: risk of target organ damage (TOD) is minimal  
 Pre-hypertensive 140-159mmHg: risk of TOD is low 
 Hypertensive 160-179mmHg: risk of TOD is moderate 
 Severely hypertensive > 180mmHg: risk of TOD is high 
 
These categories can only be guidelines as blood pressure will inevitably vary day-to-day and 
depending on circumstances. Care must be taken when measuring SBP to try and minimize the effect 
of situational hypertension (discussed below). However, these categories help provide a framework 
for the diagnosis and treatment of hypertension. 
 
Types of hypertension 
 
There are generally three categories of hypertension: situational (or white coat) hypertension, 
idiopathic (or primary) hypertension and secondary hypertension. 
 
Situational hypertension 
Cats can be prone to situational hypertension, in which stress increases SBP through autonomic 
nervous system alterations on higher centers of the central nervous system. It is difficult to quantify 
exactly how much stress can increase SBP. In the previously mentioned study of 780 healthy cats in a 
rehoming center, SBP was lowest in cats that appeared calm during the measurement (median 
112.8mmHg), increased significantly in cats deemed “cooperative but anxious” (median 123.2mmHg) 
and was significantly higher again in cats that were “nervous, excited or aggressive” during BP 
measurement (median 131.6mmHg).2 The main concern is that situational hypertension could lead to 
a false diagnosis of true hypertension and unnecessary treatment. If you obtain a high BP reading, this 
should prompt fundic examination to look for supportive evidence that true hypertension is present 
(discussed further below). However, a normal fundic exam cannot definitively rule out hypertension 
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and at present the search for biomarkers that can confirm the presence of hypertension has been 
unrewarding.6 Measurement of elevated BP on one occasion, without evidence of hypertensive 
retinopathy should be confirmed at another consultation within 1-2 weeks. It appears that cats adapt 
quickly to having BP measurement performed and a repeated measurement on a subsequent visit can 
often be lower; in three recent randomized, placebo-controlled studies for treatment of hypertension, 
18-28% of cats in the placebo arm achieved a reduction in SBP of  15% or to < 150mmHg by 28 days.7-
9 There is no evidence to suggest situational hypertension should be treated in cats. However, the 
consequences of not treating true hypertension can be severe. Therefore, if a cat demonstrates 
persistently elevated SBP (> 160mmHg) on repeated measurements on different occasions, anti-
hypertensive medication should be initiated. 
 
Another consideration is which cats should have BP measurement performed. It has been suggested 
that BP measurements should be initiated in cats from 3 years of age every 12 months, to start 
obtaining baseline readings for the individual animal.10 However, as with any test, the likelihood of a 
type 1 error, (i.e. a false positive), is increased with a lower prevalence of disease. Therefore, 
measurement of BP in young healthy cats in which the prevalence of hypertension is very low will 
inevitably produce false positive results that provide a clinical conundrum for the clinician: to treat, or 
not to treat? One study of 137 healthy cats aged 0.7-16.6 years found 21.9% of the cats had an SBP 
measurement that would assign them to the ACVIM “Hypertensive” category with moderate risk of 
TOD, and no association was found between SBP and age.5 However, none of the cats had fundic 
examination and repeat measurements were not performed to help rule out situational hypertension. 
Additionally, four cats had an SBP >180mmHg, but three of these were under 3 years of age and were 
subsequently removed from the analysis, highlighting the difficulty of deciding what to do with young 
cats that are seemingly hypertensive. As a result, the ACVIM consensus statement argues that 
screening for hypertension is reasonable on an annual basis from 9 years of age, but should not be 
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performed in younger animals,4 although consideration could be given to performing a fundic 
examination on a regular basis in cats of all ages as part of a complete physical examination.  
 
Steps should be taken to minimize stress and to reduce the type I error rate of diagnosing hypertension 
by considering the following points: 
 Only measure blood pressure in patients considered to have a possibility of having 
hypertension due to:4 
o The presence of clinical abnormalities consistent with hypertensive TOD 
o A diagnosis of a condition known to be associated with hypertension 
o Treatment with a pharmacological agent (e.g. erythropoietin, darbepoetin alfa) or 
ingestion of a toxin known to be associated with hypertension (e.g. cocaine, 
methamphetamine, 5-hydroxytryptophan; although hypertension associated 
ingestion of these toxins has only been reported in dogs to date).   
o An older cat ( 9 years of age) with possible occult disease 
 Reduce possible stress factors as much as possible (e.g. having a quieter and calmer 
environment for monitoring blood pressure or allowing more time for acclimatization before 
measuring). 
A summary of which cats should have BP measurement performed is shown in Box 1. 
 
Idiopathic hypertension 
Idiopathic hypertension seemingly accounts for approximately 13-24% of feline hypertension,11-13 
however, this is a diagnosis of exclusion and it is possible these percentages are over-estimates. If 
hypertension is diagnosed in a patient without a known underlying cause, this should prompt 





Secondary hypertension occurs in conjunction with another disease process or due to a medication or 
toxin that elevates blood pressure. This is the most common type of hypertension in cats.4,10 The exact 
etiology of hypertension in association with concurrent disease is incompletely understood. In other 
species, chronic activation of the renin-angiotensin-aldosterone system (RAAS) is known to play a role, 
however studies have failed to identify increased plasma renin activity in either hypertensive CKD 
cats14 or in hypertensive hyperthyroid cats.15 A recent study found polymorphisms in the uromodulin 
gene to be associated with SBP, but not with renal function or CKD; further work is required to explore 
the impact of these specific polymorphisms, however they may affect water and sodium handling in 
the thick ascending limb of the loop of Henle.16 
 
Diagnosis of any of the following conditions should prompt measurement of SBP and if hypertension 
is present the cat requires antihypertensive treatment in addition to treatment of the underlying 
condition. Conditions associated with secondary hypertension include: 
- Chronic kidney disease (CKD): this is the most common cause of secondary hypertension in 
cats1,12,13,17 and the prevalence of hypertension with CKD has been documented at 19-61%.18,19 
The cause and effect relationship of CKD and hypertension is complex and discussed in further 
detail below under TOD. 
- Acute kidney injury (AKI): hypertension has also been documented in 58.7% cats with 
community acquired AKI and was not related to the grade of AKI or serum creatinine.20  
- Hyperthyroidism: prevalence of hypertension varies from approximately a quarter of cases,1,12 
up to 87% of cats having systolic or diastolic hypertension in one study.19 Other studies have 
documented increasing prevalence (approximately twofold) within six months of restoration 
of euthyroidism, although a proportion of these cats also developed azotaemic CKD.15,21 There 
is no association between the prevalence of hypertension and the severity of 
hyperthyroidism.22 Therefore, documentation and treatment of hypertension in all 
hyperthyroid cats at diagnosis and at re-examinations once euthyroid is paramount. 
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- Diabetes mellitus: an association between diabetes mellitus and hypertension has been made 
in cats, although prevalence appears to be low. One study of 14 diabetic cats found a zero 
prevalence of hypertension,23 whilst another study including 66 diabetic cats found 15% to 
have hypertension, although this was not a significantly higher proportion than in the control 
cats.24 A large epidemiological study of cats with hypertension found 2.1% had a concurrent 
diagnosis of diabetes mellitus,1 although additional concurrent diseases may not have been 
thoroughly excluded. Two cats in a study of hypertensive cats with hypertensive retinopathy 
had diabetes mellitus, although one also had concurrent CKD.13 However, it would still be 
prudent to periodically check for hypertension in the diabetic feline patient. 
- Hyperaldosteronism: this is not common but should be suspected particularly if hypertension 
is documented in combination with hypokalaemia or signs of hindlimb weakness and/or 
cervical ventroflexion.25 
- Pheochromocytoma26 and Cushing’s syndrome27 can both cause hypertension, but are 





Which cats should undergo blood pressure measurement? 
- Cats with sudden onset blindness or central neurological signs 
- Cats newly diagnosed with CKD, AKI, hyperthyroidism, diabetes mellitus, hyperaldosteronism, 
Cushing’s or pheochromocytoma 
- Cats already diagnosed with CKD: BP should be checked at diagnosis and at regular intervals (e.g. 
every 3-6 months) 
- Cats at diagnosis of hyperthyroidism, at the point they become euthyroid and at subsequent re-
examinations 
- Cats already receiving medication for hypertension at all re-examinations 
- Cats receiving other pharmaceutical agents (e.g. darbepoetin alfa) or that have had toxin ingestion 






The impact of hypertension 
 
Regardless of the underlying cause, sustained increases in BP cause tissue injury and the aim of 
treatment is to prevent this damage occurring. The so-called “target organs” are at risk due to the 
presence of a rich arteriolar blood supply, or via sustained increases in systemic vascular resistance. 
Damage occurs with loss of autoregulatory mechanisms in arterial blood flow in these organs, which 
include the eyes, brain, kidney and myocardium.  
 
Target organ damage: the eyes 
The retinal vessels share similar physiological characteristics to the encephalic and cardiac 
microcirculations, therefore examination of the retinal vessels is important to detect changes that 
may compromise vision as early as possible and also to provide an indication of how hypertension may 
also be affecting other organs. Lesions that may be apparent with hypertensive retinopathy include 
haemorrhages, bullous detachments, vessel narrowing and/or tortuosity, and retinal oedema. 
Occasionally, hyphaema and vitreal haemorrhage can occur and hyphaema can lead to secondary 
glaucoma. For review of feline hypertensive retinopathy lesions, readers are referred elsewhere.28 
Cats may present with blindness and complete mydriasis and historically, restoration of vision has 
been considered unlikely,4 with documentation of some vision being regained in only 13% of blind 
eyes in one feline study.13 However, a very recent study found that vision, as assessed by menace 
response, was regained in 76 of 132 blind eyes (57.6%) in cats with hypertensive chorioretinopathy 
following treatment of their hypertension.29 Initial treatment was amlodipine monotherapy in 94% of 
the cats. Complete retinal reattachment took >60 days in some cases and persistence of vision at last 
re-examination was actually higher in cats where reattachment had taken >60 days, compared to 




The vulnerability of the eye to TOD appears variable; blood pressure was significantly higher in cats 
with retinal lesions in one study of 58 cats (SBP 262 +/- 34mmHg) when compared to other 
hypertensive cats without retinal lesions (SBP 221 +/- 34mmHg),30 but lesions have been reported in 
other studies to occur at SBP elevations as low as 168-170mmHg.13,17 In humans, choroidal vascular 
changes appear more common with an acute elevation in BP, whereas retinal vascular changes appear 
more likely with chronic hypertension.31 Additionally, hypertension due to renal diseases, particularly 
glomerular pathologies in humans, results in more severe retinopathies than in those with essential 
(i.e. idiopathic) hypertension.32 Hypertensive changes in the eye are seen in approximately 40-60% of 
geriatric cats with hypertension,11,12 and appear most common with concurrent CKD.13,33 
 
The eye is the quickest (and cheapest!) organ to evaluate for TOD, and fundic examination should be 
performed to help confirm all cases of suspected hypertension (e.g. if SBP is >160mmHg) so that 
treatment can be initiated as quickly as possible. One large epidemiological study found that ocular 
examination was not performed in 38.6% of cats diagnosed with hypertension,1 suggesting there is a 
barrier to performing this examination in first opinion practice. There are a number of methods 
available for performing fundic examination, which have been reviewed in detail elsewhere,28 but 
indirect ophthalmoscopy is an inexpensive and rapid method of examining a large field of view and 
should be widely considered prior to use of a direct ophthalmoscope.  For a guide to performing this 






How to perform indirect ophthalmoscopy (see also figures 2 and 3): 
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- Ask an assistant to help hold the patient and to keep the head still and if needed, to gently 
open the eyelids. 
- Hold a light source against the side of your head and look for a tapetal reflection. 
- Once the reflection can be seen, place a 20 dioptre or 2.2 Pan Retinal lens in front of the eye. 
- Obtaining an image of the fundus in the lens requires your eye and the light source, the lens 
and the cat’s eye to be in line with each other. Tilting the lens slightly and moving it towards 
and away from the patient can be tried to improve the image obtained.  
- Resting your third or fourth finger on the cat’s head or on your assistant’s hand can be helpful 
to improve stability. 
Tip: 
- Pupil dilation allows a more thorough examination of the fundus and is extremely helpful 
when less experienced with this technique. 
- Placing the cat in a dark room can help to achieve mydriasis, but if this is not sufficient then 





Retinal imaging software, such as VAMPIRE (Vascular Assay and Measurement Platform for Images of 
the Retina) is now starting to be used in cats to analyse vessel widths and arteriolar bifurcations.35 
Application of advanced technology such as this may help improve sensitivity of TOD detection in the 
future.  
 
Target organ damage: the brain 
TOD in the brain can result in hypertensive encephalopathy and appears more likely with a sudden 
increase in BP, an SBP > 180mmHg, or both.36 Two of four cats that underwent surgical reduction of 
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renal mass had an abrupt increase (40-50mmHg) in SBP and developed severe neurological signs of 
ataxia, blindness, stupor and seizures within 12-18 hours.37 Post mortem, these cats demonstrated 
diffuse brain oedema with cerebral arteriosclerosis.  
 
In studies of cats with spontaneous hypertension that have all had hypertensive retinopathy, 29-48% 
have had concurrent neurological signs including disorientation, seizures, depression, ataxia and 
vestibular signs.13,38 Treatment of hypertensive encephalopathy can be successful if initiated early.36,39 
Hypertension accounted for 8.1% of reactive seizures in feline patients in another study, with SBP 
measurements of 170-186mmHg; satisfactory seizure control was achieved with amlodipine in 3/5 
cases.40  
 
Target organ damage: the kidneys 
Hypertension and CKD are very common co-morbidities; azotaemia is seen in approximately 70% of 
hypertensive cats11 and conversely, approximately 60% cats with CKD are hypertensive.3,19 
Additionally, cats that are normotensive at diagnosis of CKD are significantly more likely to develop 
hypertension over time compared to healthy older cats, although the prevalence of hypertension 
increases over time in this group too (see Figure 3).3 One study has suggested that cats with later stage 
CKD may be more likely to have severe hypertension than cats in IRIS stage 2,41 but other studies have 
found no relationship between severity of CKD and severity of hypertension.3,18,19 
 
Hypertension contributes to kidney damage; increasing SBP is associated with increasing proteinuria42 
and a higher time-averaged blood pressure is associated with glomerulosclerosis and hyperplastic 
arteiolosclerosis,43 i.e. renal injury. Progressive CKD, defined by an increase in plasma creatinine >25% 
over 12 months, was also associated with proteinuria and with a higher prevalence of hypertension 
(40%) compared to cats with stable CKD over the same timeframe (29%).44 Severity of proteinuria is 
highly correlated with survival time,42 and antihypertensive treatment can reduce proteinuria11 even 
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with amlodipine monotherapy, despite the action of amlodipine to dilate the afferent arteriole, which 
should increase glomerular pressure. The glomerular pressure change is presumably offset by the 
larger decrease in systemic blood pressure, although at present it is not clear if the subsequent drop 
in proteinuria represents a reduction in kidney injury or is a surrogate marker for the changes in 
glomerular filtration rate induced by both the systemic and glomerular pressure changes.11,45  
 
Target organ damage: the heart and vasculature 
On clinical examination, 42-74% hypertensive cats have a systolic cardiac murmur30,38,46 and 13-16% 
of hypertensive cats have a gallop rhythm.30,38 Left ventricular hypertrophy (LVH) or an abnormal left 
ventricular geometric pattern is a common finding in hypertensive cats, affecting 74-85% of cases,30,46 
however, the degree of hypertrophy does not correlate with the severity of the hypertension46 and 
cause and effect remains uncertain.47 Treatment with amlodipine reduced the number of cats deemed 
to have LVH in one study, but no significant difference in any echocardiographic measurements were 
found before and after treatment.46 The effect of telmisartan on LVH in hypertensive cats has not yet 
been evaluated, however, studies in both humans and rodent models have revealed that telmisartan 
can directly inhibit cardiomyocyte hypertrophy via its actions on the cardiac angiotensin II receptor.48 
It is therefore possible that in addition to reducing SBP and therefore cardiac afterload, treatment of 
hypertensive cats with telmisartan may have additional impact on the heart. 
 
The great vessels can also be affected by hypertension. Calculating the ratio of the diameters of the 
proximal ascending aorta relative to the aortic annulus can be helpful for differentiating hypertensive 
from non-hypertensive cats.49 Additionally, severe hypertension (SBP 260mmHg) was thought to be 
the cause of a dissecting aortic aneurysm in a recent case report of a 10 year old DSH, however 
investigations into possible causes of the hypertension were not performed.50 Furthermore, a recent 
study demonstrated the presence of vasa vasorum arteriopathy in cats with hypertension.51 The vasa 
vasorum is the delicate network of arterioles that supplies blood to the walls of the great vessels. This 
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study included 24 cats, with 46% having a diagnosis of hypertension, however, this was largely based 
on clinical and/or pathological evaluation as only six cats (four hypertensive) had had their BP 
measured. Nevertheless, vasa vasorum arteriopathy correlated with hypertension status, the 
presence of renal arteriosclerosis and degenerative lesions within the great vessels.  
 
Effect on survival time 
 
Counterintuitively, numerous studies have failed to find an association between how well controlled 
hypertension is with treatment and survival time.11,12,38,42 Additionally there was no significant 
difference in survival between hypertensive cats with normal and abnormal echocardiographic 
findings.30 However, cats that present for monitoring of concurrent disease have better survival rates 
than cats diagnosed due to the presence of clinical signs, which presumably reflects owner motivation 
for monitoring and treating their cat.1 A major confounding factor to studying survival time is that the 
vast majority of cats in these studies have been treated for their hypertension. The impact of anti-
hypertensive therapy may mask the effect of hypertension on morbidity and mortality, however, 
withholding treatment would not be ethically acceptable.  
 
Survival times vary slightly between populations: cats still alive 7 days after diagnosis of hypertension 
in first-opinion practice had a median survival time of 400 days1; 24 cats with hypertensive retinopathy 
had a median survival time of 18 months38; whilst another study of 141 hypertensive cats had an 
overall survival time of only 260 days.11 In that last study, survival was strongly associated with severity 
of proteinuria at diagnosis of hypertension. Proteinuric cats with urine-protein-to-creatinine ratio 
(UPC) >0.4 survived a median of only 162 days, whereas survival time for borderline proteinuric cats 
(UPC 0.2-0.4) was 313 days and for nonproteinuric cats (UPC <0.2) it was 490 days. Importantly, UPC 




The greatest barrier to diagnosis 
 
The biggest reason that hypertension is not diagnosed is likely due to BP measurement not being 
performed. Only 4.4% of cats  9 years, had BP “assessed” during a two-year period (2012-2013) in a 
recent study of 347,889 cats in first opinion practice in the UK.1 Additionally, in some cases the 
assessment was based on ocular changes (70 cats) or clinical signs alone (five cats) and did not include 
BP measurement. The most common reason for BP assessment was presentation with clinical signs 
(63.1%), followed by monitoring of concurrent disease (31.2%). Unsurprisingly given that most cats 
had to present with clinical signs before BP was measured, over 90% of the cats diagnosed with 
hypertension were in the “severe” category. Owners of 535 cats were offered BP measurement, but 
declined. 
 
Waiting for owners to report clinical signs of illness in cats is likely to result in under-diagnosis of a 
number of common conditions including hypertension. A study of 100 apparently healthy cats aged 6 
years and over, found 8 cats had SBP >160mmHg, of which four were borderline proteinuric and one 
had a heart murmur, although no fundic lesions were reported and repeat SBP measurements on a 
subsequent visit were not performed.52  
 
Furthermore, in a recent online survey of owners of 1089 cats with CKD, only 3% were reported to 
have concurrent hypertension.53 As this study was an owner survey, the results will have been subject 
to self-selection bias regarding participation and it is possible some owners did not realize their cats 
had been tested for and/or diagnosed with hypertension. However, since other studies suggest 
prevalence rates of hypertension in cats with CKD of more like 20-65%, either these were very unusual 
CKD cats, or hypertension was being underdiagnosed in this cohort, which included cats in numerous 
countries. Creatinine concentration is an independent risk factor for becoming hypertensive,3 and the 
frequency of severe hypertension increases as International Renal Interest Society (IRIS) stage 
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increases in cats with CKD.41 However, 17% of cats that are normotensive at diagnosis of azotemic CKD 
can still go on to develop hypertension later.3 It is therefore recommended that SBP should be 
measured at CKD diagnosis and if normal, every 3-6 months thereafter. Similarly, given the high 
prevalence of hypertension at diagnosis of hyperthyroidism (25-87%)1,12,19 and increasing prevalence 
following treatment15,21 it is recommended that SBP should be measured at diagnosis of 
hyperthyroidism, on restoration of euthyroidism and every 3-6 months thereafter. 
 
Diagnosing hypertension in cats 
 
Tips for performing blood pressure measurement: 
 Let the cat acclimatize to the environment for 5-10 minutes, this could be during history 
taking. Ideally let the cat be in or out of the cat carrier as they prefer but take the top of the 
carrier off if they are to be allowed to stay in there, so that the SBP measurement can be 
performed with them in the box. 
 If the cat is already hospitalized, then blood pressure could be taken in the kennel if the cat 
seems relaxed with you doing so.  
 However, do not specifically hospitalize a cat for SBP measurement, as this may stress them 
more.  
 Use Doppler or high definition oscillometry (HDO),54 as traditional oscillometry does not 
perform reliably in cats.55 If using HDO, the tail may be the easiest place to place the cuff. The 
HDO needs to be coupled to a computer to confirm that the pulse waves produce an adequate 
trace. Further information on this is available elsewhere.10 
 Try not to shave any fur off (if you have to because the pulse is difficult to find, then they need 
time to relax again afterwards), instead wet the fur and skin with surgical spirit but try not to 
get it on their pads because it is cold and they don’t like it. 
17 
 
 Have the cat held by the owner if possible, or by someone comfortable and familiar with cats. 
The restraint should be as light as possible. Place a cuff (width should be 30-40% of the 
diameter of the leg) around one of the limbs or around the tail. 
 Use plenty of gel with your probe to find the pulse and keep the volume of the Doppler 
machine low or use headphones.  
 Inflate the sphygmomanometer to 20-40 mmHg above where the sound of the pulse vanishes 
and then slowly release the pressure. Ignore the first reading. 
 Take 5-7 readings and record them all if possible. If the readings are all trending in one 
direction, then discount them and take another 5 readings. The aim is to have 5 similar 
readings and then take the mean of those 5 as your overall reading.  
 Record what cuff size and which f used. Repeated measurements on other occasions should 
ideally have the same person performing the measurement and replicate the same cuff and 
the same leg or tail.  
 An average SBP reading >160mmHg should prompt fundic examination to help differentiate 
true hypertension from situational hypertension.  
 Treatment should be initiated immediately in cats with SBP >160mmHg and evidence of TOD.  
 If there is no evidence of TOD then BP measurement should be repeated, ideally within two 
weeks, and treatment recommended if SBP is still >160mmHg. 
 
Treatment of feline hypertension 
 
There are two first line treatment options for feline hypertension: the calcium channel antagonist 
amlodipine besylate, and the angiotensin II receptor blocker telmisartan. Both have been evaluated 
in prospective, randomized, placebo-controlled clinical trials of hypertensive cats with SBP 160-
200mmHg that did not have evidence of target organ damage.7-9 Initial reductions of 20-30 mmHg can 




Traditionally, the recommended starting dose of amlodipine is 0.625mg per cat q24h PO. However, 
cats that require a dose increase to achieve adequate control of their hypertension have a higher SBP 
at baseline,1,56 and recent evidence suggests that if baseline SBP is >200mmHg a starting dose of 
1.25mg per cat q24h PO should be considered.56 If needed, amlodipine can be increased to a maximum 
of 2.5mg per cat q24h PO, but this is rarely necessary and should prompt a careful discussion with the 
owner to check compliance.  
 
The recommended starting dose of telmisartan is 2mg/kg q24h PO in Europe1 and with an initial 14 
days of 1.5mg/kg q12h PO in the USA, then subsequent reduction to 2mg/kg q24h.2 The dose may 
need to be decreased at a later date depending on response. There are no current studies comparing 
amlodipine with telmisartan and treatment choice is largely clinician dependent at present. However, 
data on the use of telmisartan for cats with SBP >200 mmHg or with target organ damage is currently 
lacking, excepting one case report of its use in a cat with amlodipine-induced gingival hyperplasia.57 
Treatment with amlodipine has been shown to ameliorate numerous types of TOD. Amlodipine 
treatment reduced the proportion of cats with ventricular hypertrophy from 11/14 to 6/14.46 In 70% 
of cats, sole agent amlodipine reduced UPC by a median of 0.12.11 Amlodipine treatment can result in 
resolution of reactive seizures40 and reduction in other signs of hypertensive encephalopathy and 
retinopathy.36 Treatment with amlodipine, when used as a sole agent in 94% of 88 cats with 
hypertensive choriorentinopathy, resulting in 57.6% cats with bilateral blindness regaining some 
vision as assessed by the menace response.29 
 
Because antihypertensive treatment can reduce proteinuria,11 the priority in cats that are both 
hypertensive and proteinuric (UPC >0.4) is to adequately control blood pressure first and then to 





reassess UPC to see if additional anti-proteinuric therapy is required. As noted in a small number of 
cats, the combination of amlodipine with telmisartan appears to be well tolerated,58 therefore if 
required, a second agent can be added to the treatment regime.  
 
Interestingly, unlike in humans, dietary sodium chloride supplementation has not been found to affect 
renal function or blood pressure in either healthy older cats59 or in cats with nephrectomy models of 
CKD.60 However, dietary sodium chloride restriction in feline nephrectomy models can activate the 
RAAS, reduce GFR and result in urinary potassium wasting,60 therefore it is prudent to avoid dietary 
salt restriction in hypertensive cats.  
 
Although widely used as antihypertensive therapy in dogs, angiotensin converting enzyme (ACE) 
inhibitors are not recommended for monotherapy use in cats with hypertension because the 
reduction in SBP is typically only around 10mmHg and is therefore unlikely to be sufficient for most 
cats. Additionally, beta blockers (e.g. atenolol) have limited effect on blood pressure and are not 
therefore recommended for feline hypertension.  
 
Following initiation of treatment, cats should be reassessed every 7-10 days for blood pressure 
measurement and dosages tailored to achieve an SBP of <160 mmHg at a minimum and preferably 
<140 mmHg. However, SBP <110 mmHg or <120 mmHg in conjunction with lethargy/weakness should 
raise concern for hypotension prompt a reduction in antihypertensive medication dose. SBP should 
be rechecked on all future examinations if a cat is on antihypertensive medication.  
 
Hypertensive crises 
Cats presenting with an acute hypertensive crisis, particularly those with SBP  180mmHg with signs 
of intracranial TOD require emergency treatment and 24-hour care, therefore referral should be 
sought if 24-hour care cannot otherwise be provided.4,10 Intravenous medications are likely to be 
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required and blood pressure needs to be carefully and gradually decreased. Evidence for medication 




Hypertension is common in cats, particularly older cats and those with certain co-morbidities. It is 
crucial that small animal clinicians identify at-risk patients and assess for hypertension before being 
presented with a patient already showing clinical signs. However, any patient already exhibiting TOD 
should have treatment initiated immediately, then be carefully re-examined to assess response and 
change treatment doses as needed. Hypertension that is detected and controlled produces excellent 
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Figure 1: Complete retinal detachment and mydriasis in a cat that had never previously had blood 
pressure measurement performed. 
 
Figure 2A: To perform indirect ophthalmoscopy, ask an assistant to gently restrain your patient, 
hold a light source next to your head and stand nearly an arm’s length away from your patient. 
 
Figure 2B: Look for a tapetal reflection and then place your lens between you and the cat’s eye, 
moving it slowly until you see the fundus. In the correct position the fundus will fill the lens. 
 
Figure 3: Kaplan–Meier curve of probability to become hypertensive. CKD; chronic kidney disease, 
time is in days from first visit. Cats with CKD have a greater probability to be hypertensive at each 
time point than healthy cats (P<.001). Censored cases are represented by ticks. Figure from 
“Changes in Systolic Blood Pressure over Time in Healthy Cats and Cats with Chronic Kidney 
Disease.” E.S. Bijsmans, R.E.Jepson, Y.M. Chang et al. JVIM 2015: 29(3); 858 
 
